Stocktoria
Phio Pharmaceuticals Corp. PHIO
Phio Pharmaceuticals Corp. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | — | -42795.2% | -5336.2% | -93746.7% | -47447.4% |
| Net margin | — | — | — | — | — | — | -42419.0% | -5333.3% | -83013.3% | -47336.8% |
| FCF margin | — | — | — | — | — | — | -41509.5% | -5452.9% | -64780.0% | -40863.2% |
| Return on assets | -40.5% | -124.6% | -115.6% | -89.6% | -52.8% | -55.9% | -110.8% | -48.0% | -303.9% | -67.1% |
| Return on equity | -43.2% | -151.4% | -140.1% | -105.9% | -60.6% | -67.6% | -155.0% | -54.2% | -679.3% | -82.9% |
| Debt / equity | — | — | — | — | 0.00× | 0.02× | 0.00× | — | — | — |
| Current ratio | — | 5.65 | 5.71 | 6.42 | 8.06 | 6.91 | 3.88 | 8.69 | 1.69 | 5.16 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.